CLARAGEN INC has a total of 27 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and agriculture are BETAGENON AB, DEFIANTE FARMACEUTICA LDA and LOCOMOGENE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | China | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Israel | 2 | |
#7 | Republic of Korea | 2 | |
#8 | United States | 2 | |
#9 | Brazil | 1 | |
#10 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Agriculture | |
#4 | Organic fine chemistry | |
#5 | Environmental technology | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Animal care | |
#4 | Therapeutic chemical compounds | |
#5 | Specific use of cosmetics | |
#6 | Microorganisms | |
#7 | Climate change adaptation technologies | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Zhang Zhongjian | 14 |
#2 | Mukherjee Anil B | 13 |
#3 | Pilon Aprile L | 12 |
#4 | Pilon Aprile | 6 |
#5 | Pilon April L | 4 |
#6 | Welch Richard W | 4 |
#7 | Welch Richard E | 4 |
#8 | Wiese Laura | 3 |
#9 | Antico Giovanni | 3 |
#10 | Farrow Jeffrey | 3 |
Publication | Filing date | Title |
---|---|---|
AU2002300876B2 | Use of Recombinant Human Uteroglobin in Treatment of Inflammatory and Fibrotic Conditions | |
US7122344B2 | Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions | |
CA2405946A1 | Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production | |
BR9912279A | Use of recombinant human uteroglobin in the treatment of inflammatory and fibrotic conditions | |
CN1281367A | Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |